Harvard Bioscience, Inc. (HBIO) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Harvard Bioscience, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.457 Good day, and welcome to the Q1, 2026 Harvard Biosciences, Inc. 00:00:04.457 -- 00:00:09.163 Earnings Conference Call. At this time, all participants are in listen-only mode. 00:00:09.163 -- 00:00:12.787 After the speaker's presentation, there will be a question and answer session. 00:00:12.787 -- 00:00:16.933 To ask a question, you will need to press star 1-1 on your touch-tone telephone. 00:00:16.933 -- 00:00:21.078 Please note this call is being recorded. I would like to turn the call over to Taylor 00:00:21.078 -- 00:00:24.222 Krafchick, Senior Vice President, Edelestis TA. 00:00:24.222 -- 00:00:26.662 Please go ahead. 00:00:27.126 -- 00:00:29.444 Thank you, operator, and good morning, everyone. 00:00:29.444 -- 00:00:33.970 Thank you for joining the Harvard Bioscience first quarter 2026 earnings conference call. 00:00:33.970 -- 00:00:37.574 Leading the call today will be John Duke, President and Chief Executive Officer, and 00:00:37.574 -- 00:00:40.795 Mark Frost, Chief Financial Officer. 00:00:41.018 -- 00:00:42.640 In conjunction 00:00:42.640 -- 00:00:46.645 with today's recorded call, we have provided the presentation that will be referenced 00:00:46.645 -- 00:00:49.829 during our remarks that is posted to the investor relations section of our website at 00:00:49.829 -- 00:00:51.829 investor.harvardbioscience.com. 00:00:52.572 -- 00:00:56.590 Please note the statements made in today's discussion that are not historical facts, 00:00:56.590 -- 00:01:00.074 including statements on management's expectations of future events or future financial 00:01:00.074 -- 00:01:03.415 performance, and forward-looking statements, 00:01:03.557 -- 00:01:08.903 and are made pursuant to the Safe Harbor provisions of the Private Securities Litigat...